Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions

Transfusion

Volumn 55, Issue 6, 2015, Pages 1195-1205

  Bruhn, Roberta ^a   Lelie, Nico ^b   Busch, Michael ^a   Kleinman, Steven ^c   Vermeulen, Marion ^d   Reddy, Ravi ^d   Bird, Arthur ^e   Cable, Russell ^e   Goubran, Heidi ^f   Moftah, Faten ^f   El Ekiaby, Magdy ^g   Ghiazza, Paola ^h   Manzini, Paola ⁱ   Favilli, Flavia ^j   Peduzzi, Cecilia ^k   Roig, Roberto ^l   Alvarez, Manolo ^l   Sauleda, Silvia ^m   Niederhauser, Christoph ⁿ   Levicnik, Snezna ^o   Nograsek, Polona ^o   Wessberg, Sussanne ^p   Elkblom, Sussane ^p   Lankinen, Mervi ^p   Ulm, Henrik ^q   Harritshoj, Lene ^q   Nielsen, Christian ^r   Jorgensen, Steffen ^s   Erikstrup, Christian ^t   O'Riordan, Joan ^u   Brojer, Ewa ^v   Grabarczyk, Piotr ^v   Gdowska, Jolanta ^w   Piotrowski, Dariusz ^w   Lam, Sally ^x   Teo, Diane ^x   Chua, Sze Sze ^x   Lin, Che Kit ^y   Tsoi, Wai Chiu ^y   Bon, Abdul Hamid ^z   Peng, Sally Lam Tsuey ^z   Flanagan, Peter ^aa   Brown, Stewart ^ab   Kiely, Philip ^ab   Margaritis, Angelo ^ab   more..

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b Lelie Research   (France)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d SOUTH AFRICAN NATIONAL BLOOD SERVICE   (South Africa)

^e Western Province Blood Transfusion Service   (South Africa)

^f National Blood Transfusion Center   (Egypt)

^g Shabrawishi Hospital   (Egypt)

^h CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

ⁱ MOLINETTE HOSPITAL   (Italy)

^j UNIVERSITY OF PISA   (Italy)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

^l Valencia Transfusion Center   (Spain)

^m BANC DE SANG I TEIXITS   (Spain)

ⁿ Blood Transfusion Service SRC Berne   (Switzerland)

^o BLOOD TRANSFUSION CENTRE OF SLOVENIA   (Slovenia)

^p FINNISH RED CROSS BLOOD SERVICE   (Finland)

^q Mental Health Center Glostrup   (Denmark)

^r ODENSE UNIVERSITY HOSPITAL   (Denmark)

^s Transfusion Center   (Denmark)

^t AARHUS UNIVERSITY HOSPITAL   (Denmark)

^u IRISH BLOOD TRANSFUSION SERVICE   (Ireland)

^v INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^w Regional Centre of Blood Transfusion   (Poland)

^x HEALTH SCIENCES AUTHORITY   (Singapore)

^y Hong Kong Red Cross Blood Transfusion Service   (Hong Kong)

^z National Blood Center   (Malaysia)

^aa New Zealand Blood Service   (New Zealand)

^ab AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS RNA; HEPATITIS C ANTIBODY; HEPATITIS C ANTIGEN;

ARTICLE; BIOASSAY; BLOOD BANK; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELISA KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; HEALTH CARE ORGANIZATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; PROBABILITY; RISK FACTOR; SCREENING TEST; SEROLOGY; VIRUS STRAIN; VIRUS TRANSMISSION; ADVERSE EFFECTS; AFRICA; BIOLOGICAL MODEL; BLOOD; BLOOD SAFETY; CLINICAL TRIAL; COMPARATIVE STUDY; DONOR SELECTION; EUROPE; EVALUATION STUDY; GENETICS; HEALTH; HEPACIVIRUS; IMMUNOLOGY; INCIDENCE; PACIFIC ISLANDS; PROCEDURES; RISK; SOUTHEAST ASIA; STATISTICS AND NUMERICAL DATA; TRANSMISSION; VIREMIA; VIRUS LOAD;

AFRICA; ASIA, SOUTHEASTERN; BLOOD DONORS; BLOOD SAFETY; DONOR SELECTION; ERYTHROCYTE TRANSFUSION; EUROPE; GLOBAL HEALTH; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS C ANTIGENS; HUMANS; INCIDENCE; MODELS, BIOLOGICAL; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OCEANIA; RISK; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; SEROLOGIC TESTS; VIRAL LOAD; VIREMIA;

EID: 84930869051     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13024     Document Type: Article

References (18)

1. Roth WK, Busch MP, Schuller A, et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2012;102:82-90.
2. Moiz B, Moatter T, Shaikh U, et al. Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan. Transfusion 2014;54:1652-9.
3. Bruhn R, Lelie N, Custer B, et al. Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios. Transfusion 2013;53:2399-412.
4. Lelie N, Bruhn R, Custer B, et al.; Group IIDNS. Prevalence of HBV infection in six geographical regions and clinical sensitivity of HBsAg and HBV-DNA screening. Vox Sang 2013;105(Suppl 1):55-6.
5. El Ekiaby M, Moftah F, Goubran H, et al. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios. Transfusion 2015;55:XX-XX.
6. Liu G, Holmberg SD, Kamili S, et al. Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010. Dig Dis Sci 2014;59:1950-7.
7. Weusten J, Vermeulen M, van Drimmelen H, et al. Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion 2011;51:203-15.
8. Busch MP, Glynn SA, Stramer SL, et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 2005;45:254-64.
9. Glynn SA, Wright DJ, Kleinman SH, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005;45:994-1002.
10. Kleinman SH, Lelie N, Busch MP. Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion. Transfusion 2009;49:2454-89.
11. Katayama K, Kumagai J, Komiya Y, et al. Titration of hepatitis C virus in chimpanzees for determining the copy number required for transmission. Intervirology 2004;47:57-64.
12. Grabarczyk P, van Drimmelen H, Kopacz A, et al. Head-to-head comparison of two transcription-mediated amplification assay versions for detection of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus Type 1 in blood donors. Transfusion 2013;53:2512-24.
13. Zou S, Dorsey KA, Notari EP, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion 2010;50:1495-504.
14. Lieshout-Krikke RW, Zaaijer HL, van de Laar TJ. Predonation screening of candidate donors and prevention of window period donations. Transfusion 2014 [Epub ahead of print].
15. Damen M, Zaaijer HL, Cuypers HT, et al. Reliability of the third-generation recombinant immunoblot assay for hepatitis C virus. Transfusion 1995;35:745-9.
16. van Hulst M, Hubben GA, Sagoe KW, et al. Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands. Transfusion 2009;49:2729-42.
17. World Health Organization. Screening donated blood for transfusion-transmissible infections: recommendations. Geneva, Switzerland: World Health Organization; 2009.
18. European Union. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. Brussels, Belgium: Official Journal of the European Union; 2003.